About Maxwell Biotech Venture Fund
Maxwell Biotech is the first Russian venture fund fully dedicated to investments in the life sciences sector. The fund has been created with the participation of the Russian Venture Capital (RVC), a government-sponsored fund of funds that has a mission of promoting the development of innovation-based economy in the country. Maxwell Biotech Venture Fund is managed by one of the leading Russian financial firms, Maxwell Asset Management, that has engaged a dedicated team of professionals with decades of experience in healthcare, biotechnology and investment banking industry. In addition, the fund partners with the Maxwell Biotech Group in making portfolio investments, and a list of the fund's current investments can be found in Our Portfolio. Maxwell Biotech Venture Fund has offices in Moscow, Russia and Boston, USA.